Baxter to Present at the 2019 Wells Fargo Healthcare ConferenceAllbiopro2019-08-14T09:08:10+09:008월 14th, 2019|
HCB Health Announces 14 Hires, Major Staffing of BioPharma UnitAllbiopro2019-08-14T09:06:32+09:008월 14th, 2019|
Taking Osteoporosis Drugs Can Reduce Premature Mortality Risk by Up to 39%Allbiopro2019-08-14T09:05:58+09:008월 14th, 2019|
CureVac and Yale Team Up for mRNA-Based Lung TherapiesAllbiopro2019-08-14T09:05:25+09:008월 14th, 2019|
Pharming Bolsters Immunology Pipeline with Novartis APDS Licensing DealAllbiopro2019-08-14T09:04:53+09:008월 14th, 2019|
GSK Experiences Another Leadership Shakeup with Departure of U.S. Pharma HeadAllbiopro2019-08-14T09:04:19+09:008월 14th, 2019|
Deciphera Soars on Positive Late-Stage Data in Gastrointestinal Stromal TumorsAllbiopro2019-08-14T09:03:47+09:008월 14th, 2019|
Regeneron’s Busy Month: Eylea, Ebola Treatment and DupixentAllbiopro2019-08-14T09:03:14+09:008월 14th, 2019|
Lilly’s Taltz Shows Superiority Over J&J’s Tremfya In Psoriasis StudyAllbiopro2019-08-14T09:01:45+09:008월 14th, 2019|
Senate panel launches probe into Novartis’ ‘reprehensible’ response to Zolgensma data irregularitiesAllbiopro2019-08-14T09:01:11+09:008월 14th, 2019|
Novartis inspection puts into question who knew what—and when—about Zolgensma data manipulation Allbiopro2019-08-14T09:00:37+09:008월 14th, 2019|
Regeneron’s Eylea snags pre-filled syringe approval as Novartis rival loomsAllbiopro2019-08-14T09:00:06+09:008월 14th, 2019|
Eli Lilly’s Taltz bests J&J rival Tremfya in head-to-head psoriasis tiltAllbiopro2019-08-14T08:59:34+09:008월 14th, 2019|
Embattled Sun Pharma’s Dilip Shanghvi, with Rs 1 salary, ranks among lowest-paid pharma CEOsAllbiopro2019-08-14T08:59:00+09:008월 14th, 2019|
